Bio-Tissue Revenue and Competitors
Estimated Revenue & Valuation
- Bio-Tissue's estimated annual revenue is currently $62.9M per year.
- Bio-Tissue's estimated revenue per employee is $155,000
Employee Data
- Bio-Tissue has 406 Employees.
- Bio-Tissue grew their employee count by 39% last year.
Bio-Tissue's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Scientific Officer/Founder | Reveal Email/Phone |
2 | CFO | Reveal Email/Phone |
3 | CIO | Reveal Email/Phone |
4 | VP Marketing | Reveal Email/Phone |
5 | VP IT and Operational Excellence | Reveal Email/Phone |
6 | VP Regulatory Affairs | Reveal Email/Phone |
7 | VP Human Resources | Reveal Email/Phone |
8 | Chief Commercial Officer (CCO) | Reveal Email/Phone |
9 | Chief Technology Officer | Reveal Email/Phone |
10 | Director Regulatory Affairs | Reveal Email/Phone |
Bio-Tissue Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $15.3M | 99 | 5% | N/A | N/A |
#2 | $1.1M | 7 | -30% | N/A | N/A |
#3 | $3.7M | 24 | 4% | N/A | N/A |
#4 | $4.3M | 28 | -3% | N/A | N/A |
#5 | $2.5M | 16 | N/A | N/A | N/A |
#6 | $0.8M | 5 | 0% | N/A | N/A |
#7 | $1.1M | 7 | 0% | N/A | N/A |
#8 | $2.5M | 16 | 7% | N/A | N/A |
#9 | $1.4M | 9 | -25% | N/A | N/A |
#10 | $0.6M | 4 | 0% | N/A | N/A |
What Is Bio-Tissue?
Bio-Tissue (www.biotissue.com), a business unit of TissueTech, Inc., develops and markets regenerative therapies that allow eye care professionals to advance the standard of care for treating the ocular surface. Its core products include cryopreserved amniotic membrane and umbilical cord-based tissue with innate therapeutic actions scientifically proven to heal the ocular surface. The Company’s proprietary CryoTek® preservation method ensures the tissue retains its biologic activity and healing components. To date, more than 300,000 allografts have been transplanted collectively by Bio-Tissue and sister company Amniox Medical (TissueTech business units).
keywords:N/A
N/A
Total Funding
406
Number of Employees
$62.9M
Revenue (est)
39%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Bio-Tissue News
Satellite Bio lifts off with $110M to fuel development of its implantable tissue therapies · Amgen opts to DARP-out after seeing early data from...
Satellite Bio reveals pioneering Tissue Therapeutics, bioengineered tissues that restore organ function, bringing hope across diseases. Tweet...
The company aims to translate the work of Bhatia, Chen and their cofounder Arnav Chhabra into tissue therapeutics regenerative medicines...
MIAMI, March 1, 2021 /PRNewswire/ -- Bio-Tissue, Inc., a TissueTech, Inc. company and pioneer in the clinical application of human birth tissue-based products, announced today that its parent company TissueTech had received clearance from the U.S. Food and Drug Administration (FDA) to proceed ...
Other Companies in Miami
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $15M | 408 | 75% | N/A |
#2 | $102.9M | 410 | N/A | N/A |
#3 | $109.3M | 410 | 10% | $12M |
#4 | N/A | 411 | 7% | N/A |
#5 | $35M | 414 | -6% | N/A |